{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:14:48Z","timestamp":1770912888799,"version":"3.50.1"},"reference-count":22,"publisher":"Impact Journals, LLC","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,5,31]]},"DOI":"10.18632\/oncotarget.9108","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T19:04:39Z","timestamp":1461956679000},"page":"33016-33024","source":"Crossref","is-referenced-by-count":37,"title":["Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects"],"prefix":"10.18632","volume":"7","author":[{"given":"Martin","family":"Culen","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Borsky","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic"},{"name":"Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Nemethova","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic"},{"name":"Polymer Institute of the Slovak Academy of Sciences, Bratislava, Slovak Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Razga","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic"},{"name":"Polymer Institute of the Slovak Academy of Sciences, Bratislava, Slovak Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri","family":"Smejkal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Jurcek","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic"},{"name":"Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Dvorakova","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic"},{"name":"Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Zackova","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic"},{"name":"Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbora","family":"Weinbergerova","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Semerad","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic"},{"name":"Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Sadovnik","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Haematology and Hemostaseology, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Eisenwort","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Haematology and Hemostaseology, Medical University of Vienna, Vienna, Austria"},{"name":"Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Herrmann","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Haematology and Hemostaseology, Medical University of Vienna, Vienna, Austria"},{"name":"Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Haematology and Hemostaseology, Medical University of Vienna, Vienna, Austria"},{"name":"Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri","family":"Mayer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic"},{"name":"Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic"},{"name":"Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zdenek","family":"Racil","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic"},{"name":"Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic"},{"name":"Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,4,29]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer","volume":"7","author":"Barnes","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/leu.2009.38","article-title":"Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia","volume":"23","author":"Hughes","year":"2009","journal-title":"Leukemia"},{"key":"3","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Sawyers","year":"2001","journal-title":"New Engl J Med"},{"key":"4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571","volume":"99","author":"Holyoake","year":"2002","journal-title":"Blood"},{"key":"5","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","article-title":"Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment","volume":"101","author":"Forman","year":"2003","journal-title":"Blood"},{"key":"6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejca.2011.08.015","article-title":"Quantitative monitoring of BCR\/ABL1 mutants for surveillance of subclone-evolution, -expansion, and -depletion in chronic myeloid leukaemia","volume":"48","author":"Lion","year":"2012","journal-title":"Eur J Cancer"},{"key":"7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/leu.2011.187","article-title":"Dynamics of the emergence of dasatinib and nilotinib resistance in imatinib-resistant CML patients","volume":"26","author":"Hochhaus","year":"2012","journal-title":"Leukemia"},{"key":"8","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/stem.1678","article-title":"Concise review: cancer cells escape from oncogene addiction: understanding the mechanisms behind treatment failure for more effective targeting","volume":"32","author":"Holyoake","year":"2014","journal-title":"Stem Cells"},{"key":"9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11899-012-0121-6","article-title":"Chronic myeloid leukemia stem cell biology","volume":"7","author":"Jamieson","year":"2012","journal-title":"Curr Hematol Malig Rep"},{"key":"10","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2013-10-536078","article-title":"Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia","volume":"123","author":"Sperr","year":"2014","journal-title":"Blood"},{"key":"11","doi-asserted-by":"crossref","first-page":"16280","DOI":"10.1073\/pnas.1004408107","article-title":"Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein","volume":"107","author":"Fioretos","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10428190500272507","article-title":"Detection of molecular targets on the surface of CD34+\/CD38- stem cells in various myeloid malignancies","volume":"47","author":"Valent","year":"2006","journal-title":"Leukemia Lymphoma"},{"key":"13","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/sj.leu.2401875","article-title":"Biological effects of stroma-derived factor-1 alpha on normal and CML CD34+ haemopoietic cells","volume":"14","author":"Duhrsen","year":"2000","journal-title":"Leukemia"},{"key":"14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1634\/stemcells.20-3-259","article-title":"Immature leukemic CD34+CXCR4+ cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1","volume":"20","author":"Rechavi","year":"2002","journal-title":"Stem Cells"},{"key":"15","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/leu.2011.347","article-title":"Residual normal stem cells can be detected in newly diagnosed chronic myeloid leukemia patients by a new flow cytometric approach and predict for optimal response to imatinib","volume":"26","author":"Ossenkoppele","year":"2012","journal-title":"Leukemia"},{"key":"16","first-page":"255","article-title":"IL1RAP expression as a measure of leukemic stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome","volume":"30","author":"Fioretos","year":"2015","journal-title":"Leukemia"},{"key":"17","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/eci.12368","article-title":"DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia","volume":"44","author":"Mayer","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.stem.2007.10.001","article-title":"Identification of a Hierarchy of Multipotent Hematopoietic Progenitors in Human Cord Blood","volume":"1","author":"Weissman","year":"2007","journal-title":"Cell Stem Cell"},{"key":"19","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1182\/blood-2014-12-570200","article-title":"Hematopoietic stem cells: concepts, definitions, and the new reality","volume":"125","author":"Eaves","year":"2015","journal-title":"Blood"},{"key":"20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1078\/0171-9335-00302","article-title":"The multifunctional or moonlighting protein CD26\/DPPIV","volume":"82","author":"Van Noorden","year":"2003","journal-title":"Eur J Cell Biol"},{"key":"21","first-page":"1353","article-title":"Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon","volume":"9","author":"Gadner","year":"1995","journal-title":"Leukemia"},{"key":"22","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ymeth.2010.01.002","article-title":"Single-cell gene expression profiling using reverse transcription quantitative real-time PCR","volume":"50","author":"Bengtsson","year":"2010","journal-title":"Methods"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T21:17:55Z","timestamp":1589231875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,29]]},"references-count":22,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2016,5,31]]}},"alternative-id":["9108","27145281"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.9108","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,29]]}}}